Use of Amplatzer device for endobronchial closure of bronchopleural fistulas.
Postpneumonectomy bronchopleural fistulas (BPFs) remain difficult management problems associated with considerable morbidity and mortality. Traditional therapies have included primary repair or delayed closure with the creation of an Eloesser cavity and tissue flap reinforcement. New bronchoscopic modalities have included the use of bioglues, stents, and coils. We describe another additional, less invasive bronchoscopic modality - the use of an atrial septal closure device.
Gulkarov
Iosif
I
Division of Thoracic Surgery, Department of Cardiothoracic Surgery, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY 10021, USA.
Paul
Subroto
S
Altorki
Nasser K
NK
Lee
Paul C
PC
D000368:Aged; D001983:Bronchial Fistula / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D001999:Bronchoscopy; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery; D008297:Male; D010995:Pleural Diseases / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D011013:Pneumonectomy / Q000009:adverse effects*; D012121:Respiration, Artificial; D016156:Respiratory Tract Fistula / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D055989:Septal Occluder Device; D016896:Treatment Outcome